Literature DB >> 33064219

Are biopsies always necessary in upper and lower gastrointestinal endoscopy in children? A retrospective 10-year analysis.

Rodrigo Corsato Scomparin1,2, Pedro Luiz Toledo De Arruda Lourencao3, Giovana Tuccile Comes3, Wilson Elias De Oliveira Junior3, Marcos Curcio Angelini3, Paulo Cezar Haddad de Amorim3, Simone Antunes Terra4, Maria Aparecida Marchesan Rodrigues4, Erika Veruska Paiva Ortolan3.   

Abstract

Little attention has been given to the efficiency and validity of performing routine endoscopic biopsies in normal areas in children. This study aimed to investigate the need to perform routine biopsies in upper gastrointestinal endoscopy (UDE) and colonoscopy in normal areas by comparing macroscopy and histology. It was a 10-year retrospective analysis with the inclusion of 761 UDEs and 177 colonoscopies. Considering all segments, UDEs showed false-positive result rates of 73.11% and false-negative result rates of 14.34%. The histological results modified the initial management in 53.95% of patients. Considering all segments, colonoscopies showed false-positive result rates of 63.64% and false-negative result rates of 30.97%. The histological results modified the initial management in 34.45% of patients.
Conclusion: If biopsies were obtained only in abnormal areas, the diagnosis would be lost in 53.95% of the patients in upper endoscopies and 85.7% of the colonoscopies, which justifies routine maintenance of biopsies in macroscopically normal areas in children. What is Known: • Little attention has been given to the efficiency and validity of endoscopic biopsies of normal areas during pediatric exams. • Only a few pediatric studies have correlated macroscopic and histological findings from endoscopic biopsies, and low sensitivity and specificity, as well as poor agreement, were reported. What is New: • Our study confirms the evidence that routine biopsies from macroscopically normal areas during upper and lower digestive endoscopies can lead to histopathological diagnoses and different medical management. • This is the first research on this topic in a Latin population, from a developing country, reassuring the results obtained in previous papers from other countries.

Entities:  

Keywords:  Biopsies; Colonoscopy; Histopathological analysis; Pediatric; Upper digestive endoscopy

Mesh:

Year:  2020        PMID: 33064219     DOI: 10.1007/s00431-020-03838-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

Review 1.  Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Authors:  Alfredo J Lucendo; Javier Molina-Infante; Ángel Arias; Ulrike von Arnim; Albert J Bredenoord; Christian Bussmann; Jorge Amil Dias; Mogens Bove; Jesús González-Cervera; Helen Larsson; Stephan Miehlke; Alexandra Papadopoulou; Joaquín Rodríguez-Sánchez; Alberto Ravelli; Jukka Ronkainen; Cecilio Santander; Alain M Schoepfer; Martin A Storr; Ingrid Terreehorst; Alex Straumann; Stephen E Attwood
Journal:  United European Gastroenterol J       Date:  2017-01-23       Impact factor: 4.623

2.  Histological abnormalities in biopsies from macroscopically normal colonoscopies.

Authors:  I R Sanderson; S Boyle; C B Williams; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

Review 3.  Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Roger Chou; Christina Bougatsos; Ian Blazina; Katherine Mackey; Sara Grusing; Shelley Selph
Journal:  JAMA       Date:  2017-03-28       Impact factor: 56.272

4.  Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States.

Authors:  Karlyn D Beer; Sarah A Collier; Fan Du; Julia W Gargano
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

Review 5.  Celiac disease: a comprehensive current review.

Authors:  Giacomo Caio; Umberto Volta; Anna Sapone; Daniel A Leffler; Roberto De Giorgio; Carlo Catassi; Alessio Fasano
Journal:  BMC Med       Date:  2019-07-23       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.